Use of a highly emulsified silicone oil (hes) for the production of a medicament
OwnerHeinrich Exnerinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a silicone oil emulsion comprising 0.01-85 wt. % of silicones, particularly polydimethylsiloxanes, 0.01-90 wt. % of hydrophobic emulsifier that has an HLB value ranging from 1 to 7 and/or a hydrophilic emulsifier that has an HLB value ranging from 7 to 14 and/or 0.01-90 wt. % of a mixture of one or more hydrophobic and hydrophilic emulsifiers having an HLB value ranging from 1 to 14, and 0.1-99 wt. % of biocompatible saline solution, for producing a medicament as such or in combination with other medicaments or carrier materials for treating septic infections triggered by bacterial, viral, parasitic, and fungal causative agents or diseases in animals and humans caused by traumas.
Claims21
1-11. (canceled)
A highly emulsified silicone oil emulsion based medicament for the treatment of SIRS and/or sepsis in mammals, comprising
- 0.01-85 w/w % silicone,
- 0.01-90 w/w % of at least one emulsifier selected from
- hydrophobic emulsifier with a HLB-level of 1 to 7,
- hydrophilic emulsifier with a HLB-level of 7 to 14, and
- mixture of one or more hydrophobic and hydrophilic emulsifiers with a HLB-level of 1 to 14, and
- 0.1-99 w/w % biocompatible saline solution.
A highly emulsified silicone oil emulsion based medicament for the treatment of SIRS and/or sepsis in mammals, comprising
- 0.01-85 w/w % silicone,
- 0.01-90 w/w % of at least one emulsifier selected from
- hydrophobic emulsifier with a HLB-level of 1 to 7,
- hydrophilic emulsifier with a HLB-level of 7 to 14, and
- mixture of one or more hydrophobic and hydrophilic emulsifiers with a HLB-level of 1 to 14, and p1 0.1-99 w/w % biocompatible saline solution
- wherein said silicone and emulsifier are present in an amount sufficient to improve the ability of the mammal to recover from SIRS and sepsis.
A method for treatment of a mammal afflicted with SIRS and/or sepsis, said method comprising administering to a mammal afflicted with SIRS or sepsis at least one dose of a sufficient amount of a highly emulsified silicone oil emulsion based medicament to improve the ability of the mammal to recover from said affliction, wherein said highly emulsified silicone oil emulsion comprises:
- 0.01-85 w/w % silicone,
- 0.01-90 w/w % of at least one emulsifier selected from
- hydrophobic emulsifier with a HLB-level of 1 to 7,
- hydrophilic emulsifier with a HLB-level of 7 to 14, and
- mixture of one or more hydrophobic and hydrophilic emulsifiers with a HLB-level of 1 to 14, and
- 0.1-99 w/w % biocompatible saline solution.
Dependencies are inferred from the claim text.